| Literature DB >> 28860189 |
Silvia A Synowsky1, Sally L Shirran1, Fiona G M Cooke2, Antony N Antoniou3, Catherine H Botting1, Simon J Powis4.
Abstract
Extracellular vesicles (EVs) are released by most cell types and have been associated with multiple immunomodulatory functions. MHC class I molecules have crucial roles in antigen presentation and in eliciting immune responses and are known to be incorporated into EVs. However, the MHC class I immunopeptidome of EVs has not been established. Here, using a small-scale immunoisolation of the antigen serotypes HLA-A*02:01 and HLA-B*27:05 expressed on the Epstein-Barr virus-transformed B cell line Jesthom and MS of the eluted peptides from both cells and EVs, we identified 516 peptides that bind either HLA-A*02:01 or HLA-B*27:05. Of importance, the predicted serotype-binding affinities and peptide-anchor motifs did not significantly differ between the peptide pools isolated from cells or EVs, indicating that during EV biogenesis, no obvious editing of the MHC class I immunopeptidome occurs. These results, for the first time, establish EVs as a source of MHC class I peptides that can be used for the study of the immunopeptidome and in the discovery of potential neoantigens for immunotherapies.Entities:
Keywords: extracellular vesicles; immunology; major histocompatibility complex (MHC); mass spectrometry (MS); proteomics
Mesh:
Substances:
Year: 2017 PMID: 28860189 PMCID: PMC5641862 DOI: 10.1074/jbc.M117.805895
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157